2 news items
Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
APLS
7 May 24
is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the EMPAVELI REMS
Expert Ratings For Apellis Pharmaceuticals
APLS
15 Apr 24
-to-equity ratio of 0.57, Apellis Pharmaceuticals adopts a prudent financial strategy, indicating a balanced approach to debt management
- Prev
- 1
- Next